Combining aromatase inhibitors (AIs) and growth hormone (GH) was shown to increase the height potential in pubertal boys with idiopathic short stature (ISS) when compared to treating ISS with either drug separately, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Nelly Mauras, MD, of Nemours Children’s...
Test your clinical knowledge with the FREE Case of the Month! This month highlights Pediatric ESAP 2015/16, available on the Endocrine Society’s Center for Learning. A 5-year-old boy presents for the evaluation of precocious puberty. Medical history is notable for severe, chronic eczema requiring topical corticosteroid treatment. Review of growth records shows that growth velocity...
As the “Year of Endocrinology” continues, part of the celebration involves reaching out to experts and getting their thoughts about the most significant developments in their respective fields. To commemorate July as “Pediatric Endocrinology Month,” we asked your colleagues what they thought were the most important developments in pediatric endocrinology research or clinical care. We...
Ever since a French study linked growth hormone therapy to strokes two years ago, the debate has raged on in the endocrinology community. While most agree that more studies are needed, researchers disagree on how to proceed. Two years ago, shockwaves shook the endocrinology science community when a study purported a link between growth hormone...
Children who are often hospitalized in intensive care units are more likely to have attention deficit disorders later, and new research finds a possible culprit: a high level of plastic-softening chemicals called phthalates circulating in the blood. The researchers, presented their study results Friday at The Endocrine Society’s 98th annual meeting in Boston, suggest these chemicals,...
Misrepresentations surround the occurrence, causes, and
treatment of thyroid cancer in the pediatric patient population.
It’s not as “rare” as once thought, and despite its treatability,
there is still a ways to go in separating fact from fiction.
Children are the most delicate and unpredictable of all patients. As charming as their precociousness is, the unique challenges of treating pediatric diabetes make it difficult for researchers to create an artificial pancreas for this endearing
population.
Delayed puberty is not the mystery it once was. However, determining its
causes can often present clinicians with a difficult puzzle to piece together.
Test your clinical knowledge with the FREE Case of the Month! This month highlights Pediatric ESAP 2015/16, available on the Endocrine Society’s Center for Learning. A 5-year-old boy presents for the evaluation of precocious puberty. Medical history is notable for severe, chronic eczema requiring topical corticosteroid treatment. Review of growth records shows that growth velocity...
